BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22682917)

  • 1. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
    Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.
    Petrossians P; Daly AF; Natchev E; Maione L; Blijdorp K; Sahnoun-Fathallah M; Auriemma R; Diallo AM; Hulting AL; Ferone D; Hana V; Filipponi S; Sievers C; Nogueira C; Fajardo-Montañana C; Carvalho D; Hana V; Stalla GK; Jaffrain-Réa ML; Delemer B; Colao A; Brue T; Neggers SJCMM; Zacharieva S; Chanson P; Beckers A
    Endocr Relat Cancer; 2017 Oct; 24(10):505-518. PubMed ID: 28733467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
    Fieffe S; Morange I; Petrossians P; Chanson P; Rohmer V; Cortet C; Borson-Chazot F; Brue T; Delemer B;
    Eur J Endocrinol; 2011 Jun; 164(6):877-84. PubMed ID: 21464140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
    Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
    Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.
    Mercado M; Espinosa de los Monteros AL; Sosa E; Cheng S; Mendoza V; Hernández I; Sandoval C; Guinto G; Molina M
    Horm Res; 2004; 62(6):293-9. PubMed ID: 15542931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has acromegaly been diagnosed earlier?
    Ohno H; Yoneoka Y; Jinguji S; Watanabe N; Okada M; Fujii Y
    J Clin Neurosci; 2018 Feb; 48():138-142. PubMed ID: 29113856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A follow-up of 130 patients with acromegaly in a single centre.
    Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
    Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD; Bonert VS; Mirocha JM; Melmed S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
    Sesmilo G; Webb SM;
    Endocrinol Nutr; 2010 Feb; 57(2):39-42. PubMed ID: 20189894
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased prevalence of gallbladder polyps in acromegaly.
    Annamalai AK; Gayton EL; Webb A; Halsall DJ; Rice C; Ibram F; Chaudhry AN; Simpson HL; Berman L; Gurnell M
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1120-5. PubMed ID: 21543430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M
    Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database.
    Amodru V; Petrossians P; Colao A; Delemer B; Maione L; Neggers SJCMM; Decoudier B; Kamenicky P; Castinetti F; Hana V; Pivonello R; Carvalho D; Brue T; Beckers A; Chanson P; Cuny T
    Endocrine; 2020 Oct; 70(1):134-142. PubMed ID: 32562181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.